{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:56Z","timestamp":1793134136280,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014295","name":"Pennsylvania Council on the Arts","doi-asserted-by":"publisher","award":["BCRF 19- 074"],"award-info":[{"award-number":["BCRF 19- 074"]}],"id":[{"id":"10.13039\/100014295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014295","name":"Pennsylvania Council on the Arts","doi-asserted-by":"publisher","award":["DOD BC132057"],"award-info":[{"award-number":["DOD BC132057"]}],"id":[{"id":"10.13039\/100014295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.soc.2023.05.011","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:06:26Z","timestamp":1686881186000},"page":"663-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ"],"prefix":"10.1016","volume":"32","author":[{"given":"Sydney M.","family":"Record","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Sil Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.soc.2023.05.011_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in\u00a0situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"13","key":"10.1016\/j.soc.2023.05.011_bib2","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1245\/s10434-016-5596-2","article-title":"Active surveillance for DCIS: the importance of selection criteria and monitoring","volume":"23","author":"Grimm","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-011-1430-5","article-title":"Characterizing the impact of 25 years of DCIS treatment","volume":"129","author":"Ozanne","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.soc.2023.05.011_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrclinonc.2015.8","article-title":"Current management of lesions associated with an increased risk of breast cancer","volume":"12","author":"Morrow","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2023.05.011_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in\u00a0situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.soc.2023.05.011_bib6","first-page":"481","article-title":"Cancer statistics: Breast cancer in\u00a0situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA A Cancer J Clin"},{"issue":"22","key":"10.1016\/j.soc.2023.05.011_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jncimono\/1997.22.151","article-title":"Increases in ductal carcinoma in\u00a0situ (DCIS) of the breast in relation to mammography: a dilemma","volume":"1997","author":"Ernster","year":"1997","journal-title":"JNCI Monographs"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib8","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.soc.2023.05.011_bib9","article-title":"Surveillance, Epidemiology, and End Results (SEER) Program Populations (1969-2020) (www.seer.cancer.gov\/popdata), National Cancer Institute, DCCPS","year":"2022","journal-title":"Surveillance Research Program"},{"issue":"3","key":"10.1016\/j.soc.2023.05.011_bib10","first-page":"153","article-title":"Colorectal carcinoma: Pathologic aspects","volume":"3","author":"Fleming","year":"2012","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s13402-011-0065-1","article-title":"Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism","volume":"35","author":"Carvalho","year":"2012","journal-title":"Cell Oncol"},{"issue":"3","key":"10.1016\/j.soc.2023.05.011_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1086\/269209","article-title":"The presidential effect: the public health response to media coverage about Ronald Reagan's colon cancer episode","volume":"54","author":"Brown","year":"1990","journal-title":"Public Opin Q"},{"issue":"11","key":"10.1016\/j.soc.2023.05.011_bib13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.7326\/0003-4819-127-11-199712010-00014","article-title":"Using autopsy series to estimate the disease \u201creservoir\u201d for ductal carcinoma in\u00a0situ of the breast: how much more breast cancer can we find?","volume":"127","author":"Welch","year":"1997","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.soc.2023.05.011_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11912-019-0777-3","article-title":"Management of ductal carcinoma in\u00a0situ (DCIS) of the breast: present approaches and future directions","volume":"21","author":"Solin","year":"2019","journal-title":"Curr Oncol Rep"},{"issue":"41","key":"10.1016\/j.soc.2023.05.011_bib15","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jncimonographs\/lgq039","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in\u00a0situ of the breast","volume":"2010","year":"2010","journal-title":"JNCI Monographs"},{"issue":"7","key":"10.1016\/j.soc.2023.05.011_bib16","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in\u00a0situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.soc.2023.05.011_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.crad.2019.10.009","article-title":"Non-mass versus mass-like ultrasound patterns in ductal carcinoma in\u00a0situ: is there an association with high-risk histology?","volume":"75","author":"Gunawardena","year":"2020","journal-title":"Clin Radiol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.011_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejso.2021.10.030","article-title":"Advances and controversies in management of breast ductal carcinoma in\u00a0situ (DCIS)","volume":"48","author":"Farante","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2023.05.011_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ctrv.2010.03.007","article-title":"Current perspectives of treatment of ductal carcinoma in\u00a0situ","volume":"36","author":"Est\u00e9vez","year":"2010","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5858\/133.1.13","article-title":"College of American pathologists protocol for the reporting of ductal carcinoma in\u00a0situ","volume":"133","author":"Lester","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.soc.2023.05.011_bib21","unstructured":"NCCN Guidelines Version 4.2022 Ductal Carcinoma in Situ (DCIS). Available at: https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419. Accessed January 2023, 08."},{"issue":"12","key":"10.1016\/j.soc.2023.05.011_bib22","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1245\/s10434-016-5449-z","article-title":"Society of surgical oncology-American society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in\u00a0situ","volume":"23","author":"Morrow","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2023.05.011_bib23","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1245\/s10434-016-5446-2","article-title":"The association of surgical margins and local recurrence in women with ductal carcinoma in\u00a0situ treated with breast-conserving therapy: a meta-analysis","volume":"23","author":"Marinovich","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"10.1016\/j.soc.2023.05.011_bib24","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2016.68.3573","article-title":"Society of surgical oncology-American society for radiation oncology-american society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in\u00a0situ","volume":"34","author":"Morrow","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.soc.2023.05.011_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jamcollsurg.2020.11.019","article-title":"Impact of cavity shave margins on margin status in patients with pure ductal carcinoma in\u00a0situ","volume":"232","author":"Howard-McNatt","year":"2021","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.soc.2023.05.011_bib26","doi-asserted-by":"crossref","first-page":"e725121","DOI":"10.1155\/2012\/725121","article-title":"Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer","volume":"2012","author":"Unzeitig","year":"2012","journal-title":"International Journal of Surgical Oncology"},{"issue":"6","key":"10.1016\/j.soc.2023.05.011_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1504473","article-title":"A\u00a0randomized, controlled trial of cavity shave margins in breast cancer","volume":"373","author":"Chagpar","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.soc.2023.05.011_bib28","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1245\/s10434-011-1909-7","article-title":"Lumpectomy cavity shaved margins do not impact re-excision rates in breast cancer patients","volume":"18","author":"Coopey","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jss.2015.01.054","article-title":"Early postoperative outcomes in lumpectomy versus simple mastectomy","volume":"198","author":"Chatterjee","year":"2015","journal-title":"J\u00a0Surg Res"},{"issue":"9","key":"10.1016\/j.soc.2023.05.011_bib30","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/cncr.29199","article-title":"Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: A report from the Breast Cancer Surveillance Consortium","volume":"121","author":"Allison","year":"2015","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2023.05.011_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.breast.2009.04.003","article-title":"Post-operative radiotherapy for ductal carcinoma in\u00a0situ of the breast--a systematic review of the randomised trials","volume":"18","author":"Goodwin","year":"2009","journal-title":"Breast"},{"issue":"8","key":"10.1016\/j.soc.2023.05.011_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jso.20708","volume":"95","author":"Silverstein","year":"2007","journal-title":"J\u00a0Surg Oncol"},{"issue":"8","key":"10.1016\/j.soc.2023.05.011_bib33","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/annonc\/mdv221","article-title":"Tailoring therapies--improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015","volume":"26","author":"Coates","year":"2015","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.soc.2023.05.011_bib34","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"a biological signature for breast ductal carcinoma in\u00a0situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.soc.2023.05.011_bib35","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.ijrobp.2011.11.025","article-title":"Five year outcome of 145 patients with ductal carcinoma in\u00a0situ (DCIS) after accelerated breast radiotherapy","volume":"83","author":"Ciervide","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in\u00a0situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.soc.2023.05.011_bib37","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.soc.2023.05.011_bib38","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","article-title":"Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853","volume":"19","author":"Bijker","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.soc.2023.05.011_bib39","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1757::AID-CNCR18>3.0.CO;2-V","article-title":"Long term follow-up of women with ductal carcinoma in\u00a0situ treated with breast-conserving surgery: the effect of age","volume":"86","author":"Van Zee","year":"1999","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.soc.2023.05.011_bib40","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1245\/s10434-016-5249-5","article-title":"Impact of age on risk of recurrence of ductal carcinoma in\u00a0situ: outcomes of 2996 women treated with breast-conserving surgery over 30 years","volume":"23","author":"Cronin","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.soc.2023.05.011_bib41","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1200\/JCO.19.00510","article-title":"Phase II single-arm study of preoperative letrozole for estrogen receptor-positive postmenopausal ductal carcinoma in\u00a0situ: CALGB 40903 (Alliance)","volume":"38","author":"Hwang","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.soc.2023.05.011_bib42","doi-asserted-by":"crossref","first-page":"432.e1","DOI":"10.1016\/j.urolonc.2020.11.024","article-title":"Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer","volume":"39","author":"Liu","year":"2021","journal-title":"Urol Oncol: Seminars and Original Investigations"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.21037\/tau.2017.12.24","article-title":"Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices","volume":"7","author":"Kinsella","year":"2018","journal-title":"Transl Androl Urol"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib44","first-page":"216","article-title":"Development and External Validation of the STRATified CANcer Surveillance (STRATCANS) Multivariable model for predicting progression in men with newly diagnosed prostate cancer starting active surveillance","volume":"12","author":"Light","year":"2023","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.soc.2023.05.011_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"issue":"10","key":"10.1016\/j.soc.2023.05.011_bib46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1001\/jamaoto.2017.1442","article-title":"Natural history and tumor volume kinetics of papillary thyroid cancers during active surveillance","volume":"143","author":"Tuttle","year":"2017","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.soc.2023.05.011_bib47","doi-asserted-by":"crossref","first-page":"e026797","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in\u00a0situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.soc.2023.05.011_bib48","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in\u00a0situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.soc.2023.05.011_bib49","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.soc.2023.05.011_bib50","doi-asserted-by":"crossref","first-page":"djv263","DOI":"10.1093\/jnci\/djv263","article-title":"Trends in treatment patterns and outcomes for ductal carcinoma in\u00a0situ","volume":"107","author":"Worni","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320723000492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320723000492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:37:37Z","timestamp":1762360657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320723000492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1055320723000492"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2023.05.011","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to Navigate the Treatment Spectrum from Multimodality Therapy to Observation Alone for ductal carcinoma in situ","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2023.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}